Skip to content
healthcare.dev
Get a free key

Oseltamivir Phosphate for Oral Suspension

NDC 72516-029, Oseltamivir Phosphate, powder, for suspension, from Oryza Pharmaceuticals Inc..

Product NDC
72516-029
Status
Listed
Labeler
Oryza Pharmaceuticals Inc.
Dosage form
POWDER, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA217303
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72516-029 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OSELTAMIVIR PHOSPHATE6 mg/mL

Pharmacologic classes

Neuraminidase Inhibitor [EPC]; Neuraminidase Inhibitors [MoA]

Package NDCNDC-11Package
72516-029-01725160029011 BOTTLE, GLASS in 1 CARTON (72516-029-01) / 60 mL in 1 BOTTLE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/11cf45d4-0e6c-4408-bbe6-5ed94468cf2e

  • NADAC price for package 72516002901

    GET /v1/drugs/nadac/72516002901

Use it

Look up 72516-029 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72516-029 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72516-029. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.